Press release
Steady Expansion Forecast for Eye Melanoma Market, Projected to Reach $13.77 Billion by 2029
Eye Melanoma
Eye Melanoma Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for eye melanoma has seen robust growth in recent years. The market is forecasted to escalate from $9.1 billion in 2024 to $9.89 billion in 2025, proliferating at a compound annual growth rate (CAGR) of 8.7%. Factors contributing to this past growth include raised awareness and early diagnosis, an aging population and sun exposure, increased instances of skin cancer, advancements in targeted therapy, and the presence of patient advocacy and support programs.
Eye Melanoma Market Size Forecast: What's the Projected Valuation by 2029?
Forecasts for the eye melanoma market are quite positive, with predictions of notable expansion in the coming years. The market is slated to escalate to $13.77 billion by 2029, with a compound annual growth rate (CAGR) of 8.6%. The surging growth during this projection period is creditable to several factors including sustained public health efforts, investigations into genetic and molecular profiling as well as worldwide inclinations toward an older population. Key trends for the period include the incorporation of artificial intelligence (AI), the emergence of tailor-made treatment options, an emphasis on developing medication for rare diseases, patient-focused drug approval systems, progression in diagnostic imaging technology, improvement in treatment methodologies, and major technological breakthroughs in imagery.
View the full report here:
https://www.thebusinessresearchcompany.com/report/eye-melanoma-global-market-report
What Are the Drivers Transforming the Eye Melanoma Market?
The rise in eye cancer incidence is anticipated to fuel the expansion of the eye melanoma market. Eye cancer involves the growth of abnormal and unmanaged cells within the structures of the eye. The existing need for specialized therapies and interventions for early detection has been amplified due to improved detection methods, enhanced awareness, and progression in treatment alternatives. For example, the American Cancer Society reported an increase in eye and orbital cancer cases to 3,490 in 2023, up 5.12% from 3,320 in 2021, which signifies that the escalating incidence of eye cancer will boost the eye melanoma market growth. Eye Melanoma Market Driver: Growth In The Eye Melanoma Market Fueled By Increasing Geriatric Population
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13109&type=smp
What Long-Term Trends Will Define the Future of the Eye Melanoma Market?
Major corporations in the sector of eye melanoma treatment are determined to develop innovative and specific treatments like immunotherapies and targeted therapies aiming to improve the outcome and quality of life for patients. These new modes of treatments have just started to show up in the field of oncology. To illustrate, in January 2022, the U.S FDA authorized Immunocore Ltd., a British biopharmaceutical enterprise focusing on researching and developing biological drugs using soluble T-cell receptor technology to release Kimmtrak (tebentafusp-tabn). This T-cell receptor therapeutic is the first-ever treatment for those suffering from unresectable or metastatic uveal melanoma (mUM). Kimmtrak is a type of immunotherapy that zeroes in on a unique protein known as gp100 found on uveal melanoma (UM) cells. It kick-starts the immune system of the patient to eradicate melanoma by sparking specialized immune cells with defective T-cell receptors, presenting a precise approach to treating cancer.
Which Segments in the Eye Melanoma Market Offer the Most Profit Potential?
The eye melanoma market covered in this report is segmented -
1) By Site: Uvea, Sclera, Retina
2) By Diagnosis: Imaging, Biopsy, Eye Exam
3) By Treatment: Surgery, Radiation Therapy, Targeted Therapy, Immunotherapy, Other Treatment
4) By End User: Hospitals And Clinics, Academic Institutes
Subsegments:
1) By Uvea: Choroid Melanoma, Ciliary Body Melanoma, Iris Melanoma
2) By Sclera: Scleral Melanoma
3) By Retina: Retinal Melanoma
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13109&type=smp
Which Firms Dominate the Eye Melanoma Market by Market Share and Revenue in 2025?
Major companies operating in the eye melanoma market report are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi S.A., GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Koninklijke Philips N.V., Carl Zeiss AG, Genentech Inc., Elekta Instrument AB, Brainlab AG, Optos Plc, Castle Biosciences Inc., Heidelberg Engineering, Nektar Therapeutics, RaySearch Laboratories AB, Nidek Co. Ltd., IDEAYA Biosciences, Immunocore Limited, Topcon Healthcare, Oraya Therapeutics Inc., Delcath Systems Inc.
Which Regions Offer the Highest Growth Potential in the Eye Melanoma Market?
North America was the largest region in the eye melanoma market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the eye melanoma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13109
"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Steady Expansion Forecast for Eye Melanoma Market, Projected to Reach $13.77 Billion by 2029 here
News-ID: 4122507 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Melanoma
Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Marke …
The Metastatic Melanoma Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Metastatic Melanoma Therapeutics Market Size During the Forecast Period?
The market size for therapeutics in metastatic melanoma has swiftly increased in the past few years. It is projected to augment…
Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Marke …
What combination of drivers is leading to accelerated growth in the metastatic melanoma therapeutics market?
The growth of the metastatic melanoma therapeutics market is anticipated to be fueled by the increasing prevalence of melanoma cases. Melanoma, a type of skin cancer, originates in the cells, known as melanocytes, that determine the skin's pigment. Melanomas can develop on any part of the skin. Metastatic melanoma therapeutics comprise various treatments designed to interrupt…
Key Influencer in the Melanoma Therapeutics Market 2025: Surge In Melanoma Incid …
How Are the key drivers contributing to the expansion of the melanoma therapeutics market?
The rise in melanoma cases is predicted to fuel the expansion of the melanoma therapeutics market. Melanoma, a type of skin cancer, begins in the melanocytes. The therapies and medications used to treat melanoma patients and mitigate the effects of cancer are known as melanoma therapeutics. An increase in melanoma cases, therefore, leads to a surge in…
Skin Cancer Market By Cancer Type (Melanoma, Non-melanoma)
Most skin cancers are locally destructive malignant growth of the skin. They come from the epidermis cells, the skin's superficial layer. The vast majority of these types of skin cancers seldom spread (metastasize) to other areas of the body and become life-threatening, unlike cutaneous malignant melanoma.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00018117/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
• Pfizer Inc.
• Bristol-Myers Squibb Company
• Abbott Laboratories
• Amgen, Inc.
• Merck & Co., Inc.
• Novartis AG
• F. Hoffmann-La Roche Ltd
• Sanofi S.A.
• Qiagen NV
• Sun Pharmaceutical Industries Ltd…
Melanoma Diagnostics Market - Shining Light on Melanoma: Transforming Lives with …
Newark, New Castle, USA - new report, titled Melanoma Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Melanoma Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Melanoma Diagnostics market. The report offers an overview of the market, which…
Intraocular Melanoma Treatment Market Drivers
Neurological disorder diagnostics tools are medical devices, which are used in diagnosis of various neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Multiple Sclerosis. The devices which are majorly used in diagnosis are imaging tools such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and in-vitro diagnostics tools such as biomarker and biopsy. Increasing prevalence of neurological disorders in the recent past has increased demand for diagnostic…
